| Methods | Randomized controlled trial. | |
| Participants | Country: USA. Number randomized: 137. Postrandomization dropout: 3 (2.2%). Mean age: 63.2 years. Females: 62 (45.3%). Pancreatic cancer: 67 (48.9%). Biliary cancer: not mentioned. Duodenal cancer: not mentioned. Ampullary cancer: 17 (12.4%). Chronic pancreatitis: 15 (10.9%). Pancreaticoduodenectomy: 137 (100%). Distal pancreatectomy: 0 (0%). Other pancreatic surgery: 0 (0%). Inclusion criteria:
Exclusion criteria:
|
|
| Interventions | Participants (N = 137) were randomly assigned to 1 of 2 groups. Group 1: drainage (N = 68). Group 2: no drainage (N = 69). |
|
| Outcomes | Mortality, morbidity, wound infection, intra‐abdominal infection, various postoperative complications, reoperation, readmission, additional radiologic intervention, and length of hospital stay. | |
| Notes | ||
| Risk of bias | ||
| Bias | Authors' judgement | Support for judgement |
| Random sequence generation (selection bias) | Low risk | Quote: "Randomization was performed using a computerized randomization system at the coordinating center". |
| Allocation concealment (selection bias) | Unclear risk | Comment: no information provided. |
| Blinding of outcome assessment (detection bias) All outcomes | High risk | Quote: "Masking: open label". |
| Incomplete outcome data (attrition bias) All outcomes | High risk | Quote: "There were 3 cases for which the randomization group assignment was inadvertently not followed". |
| Selective reporting (reporting bias) | Low risk | Comment: the study protocol was available. All of the study's prespecified outcomes were reported. |
| Other bias | Low risk | Comment: the study appears to be free of other sources of bias. |